The Safety Lancets Market is forecast to witness considerable growth due to the increasing demand for safety lancets that are easy and efficient to use. “According to a recent study by SNS Insider, the global Safety Lancets Market size valued at USD 1.71 billion in 2025, is anticipated to grow to USD 4.95 billion by 2035, registering a CAGR of 11.21% over the 2026–2035 forecast period.”
The increasing prevalence of chronic diseases, which require regular blood tests, in addition to the increased awareness about infection control and patient safety, are contributing to the ongoing need for the development of efficient lancets. This trend is coupled with the increasing adoption of needle-stick injury-preventive devices and enhanced patient care in medical institutions.
As healthcare continues to evolve toward decentralized and patient-focused care models, there have been advancements in the development of next-generation blood collection systems that have user-friendly designs along with additional safety aspects.
To Get Detailed Insights on the Safety Lancets Market – Request a Free Sample Report
Home-Based Monitoring and Digital Healthcare Expand Market Opportunities
The rise in the prevalence of home care has revolutionized disease management across the world. People have started preferring home-based disease monitoring via easy-to-use devices that ease up the process of testing without the need for constant hospital visits.
Remote patient management has been made possible through digital healthcare platforms and monitoring devices, which help patients send their test results to healthcare experts instantly. Remote patient management will lead to the increased need for high-end safety lancets compatible with the current monitoring devices.
Healthcare institutions are also stressing on preventive disease screenings and regular health monitoring, thus providing new openings for manufacturers within the safety lancets market segment.
Key Market Findings Highlight Emerging Growth Areas
Among product categories, button-activated safety lancets accounted for 56.48% of global market revenue in 2025, reflecting their widespread preference for consistent performance, ease of operation, and improved patient comfort.
Meanwhile, pressure/contact-activated devices are projected to register the fastest growth through 2035, expanding at a CAGR of 12.14%, supported by increasing demand for simple and portable blood sampling solutions.
By incision type, needle-based safety lancets represented 61.32% of total market revenue in 2025, maintaining their leadership across clinical and home-care settings. At the same time, blade-based lancets are expected to record the fastest growth at a CAGR of 11.85%, driven by continued innovation focused on improving patient comfort and blood collection efficiency.
Application trends continue to evolve as healthcare needs expand. Blood glucose monitoring accounted for 42.15% of market revenue in 2025, highlighting the continued importance of routine diabetes management worldwide. Meanwhile, hemoglobin testing is expected to witness the fastest growth, advancing at a CAGR of 12.05% through 2035, supported by growing preventive screening initiatives and broader adoption of point-of-care diagnostics.
Among end users, hospitals and clinics accounted for 58.94% of global market revenue in 2025, while home care is projected to emerge as the fastest-growing segment, expanding at a CAGR of 12.72% throughout the forecast period, reflecting increasing consumer preference for self-monitoring and home-based disease management.
An Infographic Representation of the Global Safety Lancets Market
Innovation Continues to Improve Patient Safety
Manufacturers have introduced next generation technologies for lancets that revolve around making the device more user-friendly, less uncomfortable, and safer when collecting blood samples from patients. The latest innovations in the industry include automatic needle retraction, ergonomics, and compatibility with blood glucose monitors.
Infection control is also being bolstered with the use of one-time use devices, which minimize cross contamination and assist in meeting healthcare safety requirements.
These developments will drive increased adoption among institutional healthcare providers and consumers alike.
Regional Markets Continue to Create Strong Growth Potential Globally
North America had a market share of 38.10% in 2025, owing to the presence of modern healthcare facilities, increased awareness about chronic diseases management, and use of safety-engineered medical devices. The continued development of preventive healthcare programs and home monitoring systems is one of the key reasons behind the region's strong position.
On the other hand, the Asia Pacific is expected to be the fastest growing regional market in the coming years, growing at a CAGR of 12.14% during the forecast period. Increasing investments in the healthcare sector, increased awareness about chronic diseases management, growing diagnostic centers, and adoption of home healthcare equipment are some of the main factors.
Leading Companies Focus on Product Innovation and Patient-Centered Care
Competition within the safety lancets market remains dynamic as manufacturers continue investing in product innovation, digital integration, ergonomic design improvements, and expansion across high-growth healthcare markets.
Key companies operating in the global safety lancets market include Roche Diagnostics, Abbott Laboratories, Becton, Dickinson and Company, Terumo Medical Corporation, Cardinal Health, Nipro Corporation, Ypsomed, Owen Mumford, McKesson Corporation, and Bayer.
An SNS Insider analyst Parry Kardani commented, "Growing demand for convenient self-monitoring, combined with stronger emphasis on patient safety and infection prevention, is reshaping the safety lancets industry. Continued innovation in ergonomic design and connected healthcare technologies is expected to create significant opportunities for manufacturers over the next decade."
About the Author
Get in touch
